Viewing Study NCT01107093


Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2026-01-02 @ 1:53 PM
Study NCT ID: NCT01107093
Status: COMPLETED
Last Update Posted: 2010-08-25
First Post: 2010-04-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of CDB-2914 Versus Placebo in the Prevention of Follicular Rupture Post-luteinizing Hormone (LH) Surge
Sponsor: HRA Pharma
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 2914-007
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Erin Gainer, R&D Director
Old Organization: HRA Pharma

Collaborators